Brief: Shield Therapeutics PLC Says Hans-Peter Rudolf Is Standing Down From His Role As CFO Of Group
Oct 12 (Reuters) - Shield Therapeutics PLC STXS.L :
* HANS-PETER RUDOLF IS STANDING DOWN FROM HIS ROLE AS CHIEF
FINANCIAL OFFICER ("CFO") OF GROUP
* HANS-PETER WILL STEP DOWN FROM THIS ROLE AS OF 20 OCTOBER
2023
* PAUL SPOORS WILL ASSUME CFO RESPONSIBILITY ON AN INTERIM
BASIS
Source text for Eikon: ID:nRSL8483Pa
Further company coverage: STXS.L
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Shield Therapeutics
See all newsBrief: Shield Therapeutics To Assume Full Commercial Control Of ACCRUFeR In US
Shield Therapeutics - Shield assumes full control of ACCRUFeR® in the US
Shield Therapeutics - Interim results for the six months ended 30 Jun 26
Brief: Shield Therapeutics Says On Track For Profitability In 2026; Appoints Michael Jensen As CFO
Shield Therapeutics - Q2 and H1 2026 Trading Update